Biography
Dr. David Jablons is the Chief of General Thoracic Surgery at UCSF and the Ada Distinguished Professor of Thoracic Oncology. He leads UCSF's mesothelioma surgery program on the West Coast and has extensive experience with both P/D and EPP procedures. Dr. Jablons's research laboratory focuses on molecular signaling pathways in thoracic cancers, including the Wnt pathway, with the goal of identifying new therapeutic targets.
Education & Training
- Medical Degree — Albany Medical College (Medicine)
- Residency — Cornell University Medical Center (General Surgery)
- Fellowship — National Cancer Institute (NIH) (Surgical Oncology)
Specialties & Procedures
Clinical Specialties
- Thoracic Surgery
- Surgical Oncology
Surgical Procedures
Board Certifications
- American Board of Thoracic Surgery
- American Board of Surgery
Research Focus
Surgical management of mesothelioma, Wnt signaling pathway in thoracic cancers, and molecular targets for mesothelioma treatment.
Treatment Center
Dr. David Jablons practices at UCSF Medical Center in San Francisco, CA.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Is UCSF a mesothelioma treatment center?
Yes. Dr. Jablons leads UCSF's thoracic surgery program, which treats mesothelioma as part of a comprehensive multidisciplinary approach. UCSF is an NCI-designated comprehensive cancer center.